// App-Quantinova.ai

986 : Pro-saccades predict decline in attention over 18months in newly diagnosed Parkinson’s disease

Researchers

Presenter

  • S. Stuart

Principal Investigators

  • L. Alcock

  • J. Nell

  • R. Lawson

  • R. Morris

  • A. Yarnall

  • D. Burn

  • L. Rochester

Medical Centers

  • N/A

Locations

  • United Kingdom

Companies

  • N/A

Study Components

Therapeutic Area

  • Central Nervous System (CNS)

Disease

  • Parkinson's disease

Biomarkers

  • N/A

Drug/Treatment

  • Levodopa

Outcome

  • N/A

Study Design

  • Controlled

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved